The Bard PowerPort lawsuit is one of the largest active medical device mass torts in the United States right now. Thousands of patients claim the device fractured inside their bodies, causing serious and sometimes life-threatening injuries.
As of 2026, the litigation is consolidated in a federal MDL in Arizona with over 10,000 filed cases. Bellwether trials are now shaping what settlements could look like for individual plaintiffs.
This article covers everything you need to know. You’ll learn the current MDL status, who qualifies, what injuries are covered, what compensation looks like, and what steps to take if you or someone you love was harmed by this device.
One fact that surprises many people: you may still qualify even if your PowerPort was already surgically removed years ago.
Bard PowerPort Lawsuit Update 2026: Where Things Stand Right Now
The Bard PowerPort lawsuit is active and moving toward trial as of 2026. The multidistrict litigation, known as MDL No. 3081, is pending in the U.S. District Court for the District of Arizona.
Becton, Dickinson and Company (BD), which owns Bard Medical, faces claims from patients across the country. Plaintiffs allege the PowerPort catheter was defectively designed and prone to fracture inside the body.
The number of filed cases has grown steadily. Estimates in early 2026 place the total at well above 10,000 individual plaintiffs.
| Status Indicator | Current Detail |
|---|---|
| MDL Court | U.S. District Court, District of Arizona |
| MDL Number | MDL No. 3081 |
| Approximate Filed Cases (2026) | 10,000 plus |
| Defendant | Becton, Dickinson and Company (BD) |
| Case Phase | Bellwether selection and early trials |
This is not a class action. Each plaintiff has their own case within the consolidated MDL structure. That matters for how payouts are calculated.
BD has defended its device aggressively. The company argues the PowerPort met all regulatory standards when cleared by the FDA.
Bard PowerPort MDL Update: The Consolidated Case Explained
MDL No. 3081 is the central hub for all federal Bard PowerPort lawsuits. “MDL” stands for multidistrict litigation, which is a federal tool for grouping similar cases before one judge to avoid duplicate proceedings.
Judge David G. Campbell has presided over pretrial proceedings. The MDL allows plaintiffs nationwide to have their cases managed efficiently while still preserving individual claims.
Think of an MDL like a river system. All the individual streams (cases) flow into one main river (the MDL) for common discovery and pretrial rulings. But each stream still reaches its own destination (individual verdict or settlement).
| MDL Phase | What It Means |
|---|---|
| Consolidation | All federal cases sent to one court |
| Pretrial Discovery | Both sides gather evidence |
| Bellwether Trials | Test cases tried to gauge jury reactions |
| Potential Global Settlement | BD may negotiate based on bellwether results |
| Individual Resolution | Each case settled or tried separately |
Discovery in the MDL has produced internal BD documents that plaintiffs’ attorneys say show the company knew about fracture risks earlier than it disclosed.
That internal evidence is central to the case’s strength heading into 2026 trials.
Key Takeaway: The Bard PowerPort MDL gives individual plaintiffs a powerful collective legal structure while keeping their individual compensation claims intact.
Bard PowerPort Bellwether Trials 2026: What These Test Cases Mean
Bellwether trials are the most important development in the Bard PowerPort lawsuit right now. A bellwether trial is a test case selected by both sides and the judge to be tried first.
The results give everyone, including BD and plaintiffs’ lawyers, a realistic picture of how juries respond to the evidence. In mass tort litigation, bellwether outcomes almost always push the defendant toward settlement.
If juries find in favor of plaintiffs and award substantial damages, BD faces enormous financial exposure. That pressure typically accelerates settlement talks.
| Bellwether Factor | Why It Matters |
|---|---|
| Plaintiff-friendly verdict | Pushes BD to offer higher settlements |
| Defense-friendly verdict | May lower settlement offers |
| Mixed results | Can lead to prolonged individual trials |
| Jury sympathy for injured patients | Historically high in device fracture cases |
The specific bellwether cases selected in this MDL involve plaintiffs with clear fracture injuries and documented medical consequences. That selection strategy favors plaintiffs.
Watch bellwether outcomes closely. They are the single strongest predictor of what settlement amounts will look like for the broader plaintiff pool.
Bard PowerPort Lawsuit Trial Date 2026: Key Dates on the Calendar
The first bellwether trials in the Bard PowerPort MDL are scheduled to begin in 2026. Specific trial windows have been set by the presiding judge to push the litigation toward resolution.
Early 2026 marks a critical phase. Pretrial motions, expert witness rulings (called Daubert hearings), and jury selection procedures are all expected to proceed on a defined schedule.
| Litigation Milestone | Expected Timeframe |
|---|---|
| Daubert Expert Rulings | Early 2026 |
| First Bellwether Trial | Mid-2026 |
| Jury Verdict (First Case) | Mid to Late 2026 |
| Settlement Negotiations Escalate | Following first verdict |
| Potential Global Settlement Announcement | Late 2026 or 2027 |
These dates are not guarantees. Medical device litigation can shift when courts issue continuances or when settlement talks begin privately between the parties.
That said, the 2026 trial calendar is the most concrete timeline available for plaintiffs waiting on resolution.
Key Takeaway: Bellwether trial dates in 2026 set the clock for when real money could start flowing toward injured patients.
Bard PowerPort Settlement Amount: What Victims Could Receive
No official Bard PowerPort settlement has been announced as of 2026. Settlement amounts remain speculative until bellwether verdicts establish real benchmarks.
That said, legal analysts and plaintiffs’ attorneys have begun discussing ranges based on comparable medical device mass torts. Devices with similar fracture and migration defects have historically settled for significant sums.
Comparable cases give us useful reference points. The hernia mesh MDL, which involved implanted medical devices with similar failure mechanisms, saw individual settlements ranging from tens of thousands to several hundred thousand dollars depending on injury severity.
| Injury Severity Category | Estimated Settlement Range (Comparable Cases) |
|---|---|
| Minor complications, device intact | $20,000 to $75,000 |
| Catheter fracture, surgical removal needed | $75,000 to $250,000 |
| Fracture with organ damage or embolism | $250,000 to $750,000 plus |
| Wrongful death cases | $500,000 to $1,000,000 plus |
These are not guarantees. They reflect what similar cases have produced and what plaintiff attorneys are discussing internally.
Until BD announces a global settlement fund with defined tiers, every number is an educated estimate based on case law and MDL history.
Bard PowerPort Lawsuit Payout Per Person: Breaking Down the Numbers
Your individual payout from the Bard PowerPort lawsuit depends on several specific factors. The settlement grid, once established, assigns point values to different injury categories and then translates those points into dollar amounts.
Plaintiffs’ compensation is not one-size-fits-all. Someone who had a fractured catheter requiring emergency heart surgery will receive far more than someone who had mild complications without surgery.
| Factor That Increases Your Payout | Factor That Reduces Your Payout |
|---|---|
| Catheter fracture confirmed on imaging | No imaging documentation of fracture |
| Emergency surgical intervention | Minor outpatient procedure only |
| Organ damage or embolism | No lasting physical harm |
| Long-term disability or ongoing treatment | Full recovery with no lasting effects |
| Strong medical records from treating physician | Gaps in medical documentation |
Attorney fees also affect your net payout. Contingency fees in mass tort cases typically run between 33% and 40% of the gross settlement amount.
A $200,000 gross settlement, after a 33% attorney fee, yields approximately $134,000 to the plaintiff before any additional litigation cost deductions.
Key Takeaway: Your individual payout is shaped by the severity and documentation of your specific injury, not just membership in the overall lawsuit.
Bard PowerPort Lawsuit Compensation Explained: What Drives Your Award
Compensation in the Bard PowerPort lawsuit is built around two categories: economic damages and non-economic damages. Understanding both is important before you estimate what your case might be worth.
Economic damages are the concrete financial losses tied to your injury. They include past and future medical bills, lost wages if you missed work, and costs of future care.
Non-economic damages are harder to quantify. These include pain and suffering, loss of enjoyment of life, emotional distress, and in some cases, loss of consortium for a spouse.
| Damage Type | What It Includes |
|---|---|
| Past Medical Bills | All treatment costs from device implant to present |
| Future Medical Costs | Ongoing care, monitoring, or corrective procedures |
| Lost Wages | Income lost due to injury-related absence |
| Pain and Suffering | Physical pain, emotional trauma, quality of life impact |
| Loss of Consortium | Impact on your relationship with your spouse or partner |
| Punitive Damages | Possible in cases of gross corporate negligence |
Punitive damages are the wildcard. If plaintiffs’ attorneys can show BD knew about the fracture risk and concealed it, juries could add punitive damages on top of compensatory awards.
That is one reason those internal BD documents discovered during MDL discovery matter so much. They could unlock the punitive damages argument.
Who Qualifies for the Bard PowerPort Lawsuit?
You may qualify for the Bard PowerPort lawsuit if you had a Bard PowerPort device implanted and suffered a documented injury related to catheter fracture, migration, blood clots, or infection. The lawsuit targets a specific product family made by Bard Medical, a BD subsidiary.
Not every implanted port qualifies. The lawsuit focuses specifically on Bard PowerPort devices, including the PowerPort Slim and the PowerPort MRI, not other brands of chest ports.
| Basic Eligibility Check | Yes or No |
|---|---|
| Had a Bard PowerPort, PowerPort Slim, or PowerPort MRI implanted | Required |
| Suffered a catheter fracture, migration, clot, or infection | Required |
| Injury documented by a medical provider | Strongly recommended |
| Device implanted in the United States | Required |
| Device already removed | Does NOT disqualify you |
The “already removed” issue is one of the most commonly misunderstood aspects of this lawsuit. If your device was removed due to a fracture or complication, you very likely still qualify.
Patients whose ports were removed proactively after a recall or warning may also have valid claims depending on the documented reason for removal.
Bard PowerPort Lawsuit Eligibility Requirements in Detail
Beyond basic qualification, attorneys look at specific criteria to determine the strength of your case. The stronger your documentation, the stronger your claim.
Medical records are the foundation of any PowerPort case. Your records need to show the device was implanted, what complications occurred, and what treatment was required as a result.
| Eligibility Requirement | Detail |
|---|---|
| Device identification | Must be a Bard PowerPort product specifically |
| Implant date | No strict cutoff, but earlier implant dates may have stronger regulatory timeline arguments |
| Injury documentation | Imaging, surgical notes, hospital records |
| Treating physician records | Confirm the injury was attributed to the device |
| Statute of limitations | Varies by state, typically 2 to 3 years from date of injury discovery |
The statute of limitations is critical. In most states, you have two to three years from the date you discovered your injury to file. Some states have a “discovery rule” that starts the clock when you reasonably should have known.
Waiting is the single biggest mistake potential plaintiffs make. If you think you have a claim, the time to act is now, not after you see a settlement announced.
Key Takeaway: Strong medical records and acting before your state’s statute of limitations expires are the two most important factors in protecting your claim.
Bard PowerPort Injuries: What the Device Did to Patients
The Bard PowerPort lawsuit centers on a specific set of injuries that plaintiffs allege were caused by a defective device. These injuries are serious and in some cases required emergency intervention.
Most plaintiffs report that symptoms appeared months or years after implantation. That delayed timeline is part of why so many patients didn’t initially connect their symptoms to the device.
Common injuries alleged in the lawsuit include:
- Catheter fracture inside the body
- Catheter tip migration into the heart or lungs
- Blood clots (deep vein thrombosis or pulmonary embolism)
- Cardiac arrhythmia caused by catheter movement
- Infection at the port site or in the bloodstream
- Perforation of veins or heart tissue
- Difficulty removing a fractured catheter fragment
- Permanent damage to vessels or cardiac tissue
Some patients underwent multiple surgeries to locate and remove fractured catheter fragments. In the worst cases, fragments lodged in the heart or pulmonary arteries could not be safely retrieved.
These are not minor inconveniences. These are serious, life-altering medical events.
Bard PowerPort Catheter Fracture: The Core Defect Claim
Catheter fracture is the central defect allegation in the Bard PowerPort lawsuit. The claim is that the polyurethane catheter tubing used in the device was prone to breaking apart under normal use conditions.
When a catheter fractures, pieces of tubing can break free and travel through the bloodstream. That process is called embolization, and it carries serious risks including cardiac arrhythmia, pulmonary embolism, and death.
Picture a garden hose with a weak spot in the wall. Under normal water pressure, that weak spot eventually cracks. Inside a human body, the consequences of that crack are far more dangerous than a wet lawn.
| Catheter Fracture Stage | What Happens to the Patient |
|---|---|
| Micro-cracking begins | Usually no symptoms, invisible on routine checks |
| Visible fracture on imaging | Often discovered incidentally on X-ray or CT scan |
| Fragment breaks free | Embolization risk begins immediately |
| Fragment migrates | Travels to heart or pulmonary vessels |
| Emergency intervention needed | Surgical or catheter-based retrieval attempted |
Plaintiffs argue BD knew about fracture risks based on internal testing and post-market surveillance data. The allegation is that the company chose not to redesign the catheter or adequately warn patients and physicians.
That design defect argument, supported by internal documents, is the strongest legal theory in the case.
Bard PowerPort Migration Injury: When the Catheter Moves
Migration injuries occur when the catheter or a fractured piece of it moves from its intended position. In a properly functioning PowerPort, the catheter tip sits in the superior vena cava, a large vein near the heart.
When the catheter fractures or dislodges, that tip can travel into the right atrium, right ventricle, or pulmonary artery. Each of those locations carries distinct and serious risks.
| Migration Destination | Associated Risk |
|---|---|
| Right atrium | Arrhythmia, clot formation |
| Right ventricle | Life-threatening arrhythmia, perforation |
| Pulmonary artery | Pulmonary embolism, breathing difficulty |
| Peripheral vessel | Vessel damage, chronic pain |
Migration injuries often require urgent cardiac catheterization or open surgery to retrieve the fragment. Some fragments are inoperable due to their location or the patient’s overall health.
Patients left with an irremovable fragment face lifelong monitoring, anticoagulation therapy, and the constant risk of a cardiac event. These cases represent some of the highest-value claims in the MDL.
Key Takeaway: Migration injuries, where the catheter moves into cardiac tissue, are among the most serious and highest-compensated claims in the Bard PowerPort lawsuit.
Bard PowerPort Blood Clot Lawsuit: Thrombosis Claims Explained
Blood clot injuries are a significant category within the Bard PowerPort lawsuit. The allegation is that the device’s material and design promoted clot formation around the catheter tip and along the vessel walls.
Thrombosis means clotting inside a blood vessel. Deep vein thrombosis (DVT) near the catheter site and pulmonary embolism (PE) when clots travel to the lungs are the two most commonly reported clot-related complications.
Pulmonary embolism is a medical emergency. It can cause sudden collapse, oxygen deprivation, and death if not treated immediately.
| Clot Injury Type | Symptoms | Risk Level |
|---|---|---|
| Catheter-related thrombosis | Arm swelling, pain, redness | Moderate |
| Central vein thrombosis | Chest pain, head pressure | High |
| Pulmonary embolism | Sudden shortness of breath, chest pain | Life-threatening |
| Cardiac thrombus | Arrhythmia, stroke risk | Critical |
Blood clot claims are medically complex to litigate because cancer patients, who are the most common PowerPort recipients, already face elevated clot risks from their underlying condition.
Plaintiffs must demonstrate through expert medical testimony that the device specifically caused or significantly contributed to their clot injury beyond what their cancer treatment alone would have caused.
Bard PowerPort FDA Warning and Recall: The Regulatory Record
The FDA has issued multiple communications about Bard PowerPort devices. Understanding the regulatory history helps establish that BD was on notice about these risks before many patients were harmed.
In 2020, the FDA issued a safety communication warning about catheter fracture and embolization risks associated with certain implanted port catheters, including products in the Bard PowerPort line.
Prior to that, Bard had initiated recall actions related to specific product lots. These recalls, classified under FDA’s Class II designation in some instances, acknowledged the potential for catheter fractures.
| FDA Action | Year | Significance |
|---|---|---|
| Class II Recall (specific lots) | 2019 to 2020 | Acknowledged fracture risk in certain units |
| FDA Safety Communication | 2020 | Warned healthcare providers about catheter fracture risks |
| Ongoing MDR Reporting | 2018 onward | Medical device reports filed documenting injuries |
| 510(k) Clearance Process | Original clearance | Allowed to market without full clinical trial data |
The 510(k) clearance issue is particularly relevant. The Bard PowerPort was cleared through the FDA’s 510(k) pathway, which allows a device to reach market by demonstrating equivalence to a predicate device rather than conducting full clinical trials.
Plaintiffs argue this accelerated approval pathway allowed a defective product to reach patients without adequate safety data.
Bard PowerPort Class Action vs Mass Tort: What Is the Difference?
The Bard PowerPort lawsuit is a mass tort, not a class action. That distinction matters enormously for how much money you can receive and how your case is handled.
In a class action, plaintiffs are grouped as a single entity. One settlement is divided among everyone, often resulting in very small individual payments. Think of the $15 checks people get from tech company privacy settlements.
A mass tort treats each plaintiff as an individual with their own case. Your compensation is based on your specific injuries, your specific medical history, and your specific losses.
| Feature | Class Action | Mass Tort (MDL) |
|---|---|---|
| Individual attention to your case | Minimal | Yes, each case is individual |
| Compensation based on personal injury | No, it is shared | Yes |
| Potential payout | Often very small | Often substantially larger |
| Your attorney represents | The group | You specifically |
| Cases consolidated for efficiency | Yes | Yes, but individual claims preserved |
The Bard PowerPort MDL gives plaintiffs the efficiency of collective pretrial proceedings while preserving each person’s right to individual compensation tied to their actual injuries.
That structure is significantly more favorable to seriously injured plaintiffs than a class action would be.
Key Takeaway: The mass tort structure of the Bard PowerPort lawsuit means your compensation is tied to your injuries specifically, not divided equally among thousands of plaintiffs.
How to File a Bard PowerPort Claim in 2026
Filing a Bard PowerPort claim starts with finding a qualified plaintiffs’ attorney who handles medical device mass tort cases. You do not file directly with a court. Your attorney does that on your behalf.
Most mass tort attorneys take these cases on a contingency basis. That means you pay nothing upfront. The attorney collects a percentage of your recovery only if you win or settle.
Here is the general process for filing in 2026:
- Step 1: Contact a mass tort law firm that specifically handles Bard PowerPort cases
- Step 2: Provide your medical records documenting the device implantation and any injuries
- Step 3: Your attorney files a lawsuit in federal court, which is then transferred to MDL No. 3081 in Arizona
- Step 4: Your case enters discovery along with thousands of others
- Step 5: Depending on MDL progress, your case may be resolved through a global settlement or proceed to individual trial
| Document to Gather | Why It Matters |
|---|---|
| Implant surgical records | Confirms device brand and model |
| Device identification card | Confirms it is a Bard PowerPort specifically |
| Follow-up imaging (X-rays, CT scans) | Documents fracture or migration |
| Hospital records for complications | Documents the injury and treatment required |
| Lost wage records | Supports economic damage calculation |
Time is the most critical factor. State statutes of limitations are running. A claim that would have been valid in 2024 may be time-barred by late 2026 in some states.
Act on this now, not after you see a settlement announcement, because by then filing new claims may no longer be possible.
Frequently Asked Questions
What is the current status of the Bard PowerPort lawsuit in 2026?
The Bard PowerPort lawsuit is in active litigation in MDL No. 3081 in the U.S. District Court for the District of Arizona.
Bellwether trials are scheduled for 2026, which will set the stage for potential global settlement negotiations.
No global settlement has been announced as of early 2026.
How much money can I get from the Bard PowerPort settlement?
No official settlement amount has been set, but comparable medical device mass torts suggest individual payouts ranging from $20,000 to over $750,000 depending on injury severity.
Your specific compensation depends on your injury type, documentation, and medical history.
Amounts will become clearer after the first bellwether trial verdicts are returned in 2026.
Do I still qualify if my PowerPort was already removed?
Yes, having your PowerPort removed does not disqualify you from the lawsuit.
If the removal was caused by a fracture, migration, or other device complication, that is itself evidence supporting your claim.
Patients who had their ports removed proactively following FDA warnings may also have valid claims.
What injuries are covered in the Bard PowerPort lawsuit?
The lawsuit covers catheter fracture, catheter migration, blood clots (DVT and pulmonary embolism), cardiac arrhythmia, infection, and vessel or organ perforation.
Any injury causally linked to the Bard PowerPort device’s design defect may qualify.
Emergency surgical interventions to retrieve fractured catheter pieces are among the most serious covered injuries.
How long does the Bard PowerPort lawsuit take to settle?
Mass tort MDL litigation typically takes three to seven years from consolidation to global settlement.
The Bard PowerPort MDL was consolidated in 2023, putting a potential global settlement in the 2026 to 2028 range based on historical timelines.
Bellwether trial outcomes in 2026 will be the biggest factor in accelerating or delaying that timeline.
What You Should Do Right Now
The Bard PowerPort lawsuit is at a turning point in 2026. Bellwether trials are on the calendar, internal company documents are in play, and thousands of injured patients are waiting for resolution.
If you or someone you love had a Bard PowerPort implanted and experienced fracture, migration, blood clots, or any serious complication, your window to file is narrowing. Statutes of limitations do not pause because settlements are pending.
Gather your medical records. Contact a mass tort attorney who focuses on medical device litigation. Do not assume your case is too small or too complicated to qualify.
The legal process is already moving. The question is whether you are in it.
